Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets...

Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves...

Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers

Introducing The Psychedelic News Feed Podcast

Field Notes #5: ‘Psychedelics Week’ in Washington D.C.

Beyond the Foxhole: How Psychedelic Policy’s Coalition Is Growing Past Veterans

What Lynn Watkins Actually Told the FDA about Chronic Pain and...

‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop

Pα+ Psychedelic Bulletin #231: Compass Shares 52 Week Follow-Up, Training Grant...

No Questions Asked: FDA’s Psychedelics Public Hearing

Load more